Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,450.00p
   
  • Change Today:
      25.00p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,387
  • Market Cap: £232.27m

Latest Deals

Traded Action Notifier PriceAmountValue
29-Jan-24 Sell Peter John Harrison 4,200.00p 62,000 £2,604,000.00
27-Nov-23 Buy Bruce Hiscock 3,977.00p 17 £676.09
18-May-23 Sell Ian James Nicholson 3,651.53p 1,638 £59,812.06
18-May-23 Exercise of option Ian James Nicholson 1,350.00p 1,638 £22,113.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
29-Jan-24 Sell Peter John Harrison 4,200.00p 62,000 £2,604,000.00
18-May-23 Sell Ian James Nicholson 3,651.53p 1,638 £59,812.06
18-May-23 Exercise of option Ian James Nicholson 1,350.00p 1,638 £22,113.00
27-Nov-23 Buy Bruce Hiscock 3,977.00p 17 £676.09

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £13,220,416
Ian James Nicholson 13,000 £578,500
Bruce Hiscock 778 £34,621

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £232,274,692
Castlefield Fund Partners Limited 985,000 £43,832,500
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £39,382,500
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £27,567,750
Gresham House Asset Management Limited 577,782 £25,711,299
Miton Group plc 508,135 £22,612,008
The Diverse Income Trust plc 302,300 £13,452,350
Wasatch Advisors, Inc. 265,000 £11,792,500
Canaccord Genuity Group Inc 259,940 £11,567,330
Adrian Williams 253,372 £11,275,054

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,450.00p
Change Today 25.00p
% Change 0.57 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 1,387
Shares Issued 5.22m
Market Cap £232.27m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
74.51% above the market average74.51% above the market average74.51% above the market average74.51% above the market average74.51% above the market average
92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average
Income
29.66% below the market average29.66% below the market average29.66% below the market average29.66% below the market average29.66% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
34.04% below the market average34.04% below the market average34.04% below the market average34.04% below the market average34.04% below the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for 26-Apr-2024

Time Volume / Share Price
16:35 2 @ 4,450.00p
16:35 2 @ 4,450.00p
15:47 12 @ 4,464.00p
15:25 9 @ 4,427.00p
15:20 19 @ 4,430.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page